Search Within

Joseph G Jurcic

Formats
  1. Meeting Abstract (69)
  2. Journal Article (60)
  3. Book Section (3)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (134)
  2. Hematologic Malignancies, Division of (134)
  3. Center for Hematologic Malignancies (112)
  4. Adult Leukemia (109)
  5. GSK Faculty (99)
  6. Hematologic Malignancies Research (95)

More Groups

People
  1. David Scheinberg (84)
  2. Peter Maslak (44)
  3. Steven Larson (33)
  4. Ronald Finn (26)
  5. Mark Heaney (23)
  6. Michael Mcdevitt (23)

More People

Years
  1. 2018 (1)
  2. 2016 (1)
  3. 2014 (2)
  4. 2013 (4)
  5. 2012 (9)
  6. 2011 (13)

More Years

Publications
  1. Blood (47)
  2. Journal of Clinical Oncology (13)
  3. Journal of Nuclear Medicine (8)
  4. Cancer Biotherapy and Radiopharmaceuticals (6)
  5. Cancer Chemotherapy and Biological Response Modifiers (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Hematology (48)
  2. American Society of Clinical Oncology (13)
  3. Elsevier Inc. (12)
  4. Society of Nuclear Medicine (8)
  5. Mary Ann Liebert, Inc (6)
  6. Springer (6)

More Publishers

Results (134)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cytomorphologic and clinical features of AML with translocation (8;16) mimicking APL
    Meeting Abstract

    Jhanwar, S.; Diab, A.; Zickl, L.; Manji, G. A.; Patel, J.; Abdel-Wahab, O. I.; Jurcic, J. G.; Maslak, P. G.; Steinherz, P. G.; Paietta, E.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Decitabine for the treatment of acute myeloid leukemia (AML): Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Ganetsky, A.; Adel, N. G.; Frattini, M. G.; Maslak, P. G.; Heaney, M. L.; Jurcic, J. G.; Tallman, M. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Lintuzumab and low-dose cytarabine compared to placebo and low-dose cytarabine in patients with untreated acute myeloid leukemia (AML) 60 years and older: Results of a randomized, double-blinded phase 2b study
    Meeting Abstract

    Lancet, J. E.; Sekeres, M. A.; Wood, B. L.; Grove, L. E.; Sandalic, L.; Sievers, E. L.; Jurcic, J. G.
    Blood (2011)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Elevated mitochondrial membrane potential in CLL cells is associated with a more aggressive natural history
    Meeting Abstract

    Gardner, J. R.; Knapp, K.; Frattini, M. G.; Lamanna, N.; Brentjens, R.; Jurcic, J. G.; Maslak, P. G.; Berman, E.; Weiss, M.; Scheinberg, D. A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Administration of all-trans retinoic acid (ATRA) to newly diagnosed patients (pts) with acute promyelocytic leukemia (APL) is delayed even at experienced centers and associated with an increased early death rate (EDR): A retrospective analysis of 205 pts
    Meeting Abstract

    Altman, J. K.; Rademaker, A.; Cull, E.; Weitner, B. B.; Ofran, Y.; Rosenblat, T. L.; Haidau, A.; Park, J. H.; Ram, S.; Orsini, J.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Journal Article

    Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Induction and postremission strategies in acute myeloid leukemia: State of the art and future directions
    Journal Article

    Rosenblat, T. L.; Jurcic, J. G.
    Hematology/Oncology Clinics of North America (2011)

    Fulltext@MSK | Save
  • Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
    Journal Article

    Park, J. H.; Qiao, B.; Panageas, K. S.; Schymura, M. J.; Jurcic, J. G.; Rosenblat, T. L.; Altman, J. K.; Douer, D.; Rowe, J. M.; Tallman, M. S.
    Blood (2011)

    Fulltext@MSK | Save
  • Long-term survival after T-cell depleted allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia
    Meeting Abstract

    Linker, A.; Goldberg, J. D.; Ratan, R.; Jurcic, J.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Jenq, R.; Koehne, G.; Papadopoulos, E.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save